Determining the best treatments for the right people in rheumatology

Curr Opin Rheumatol. 2008 Mar;20(2):121-2. doi: 10.1097/BOR.0b013e3282f4e884.

Author

Daniel H Solomon¹

Affiliation

¹ Division of Rheumatology, Immunology, and Allergy, Department of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

PMID: 18349739
DOI: 10.1097/BOR.0b013e3282f4e884

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Humans
Pharmacogenetics
Randomized Controlled Trials as Topic
Registries*
Rheumatic Diseases / classification*
Rheumatic Diseases / drug therapy*
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Tumor Necrosis Factor-alpha